Daugaard Laboratory

Vancouver Prostate Centre | University of British Columbia | VAR2 Pharmaceuticals | VarCT Diagnostics | Rakovina Therapeutics

[Vancouver Prostate Centre @VanProstateCtr]

Dr. Mads Daugaard and his team at VPC have developed a pulsed laser therapy that shows potential as an initial method for targeting and destroying cancer cells. https://t.co/RVtSTKKwgx

[Daugaard Laboratory @madsdaug1]

Have a look at our latest publication describing the development and pre-clinical qualification of therapeutic antibodies targeting cancer-specific glycosaminoglycans (sugar molecules).
https://t.co/vU5KNzf7p8
@VCHResearch @VanProstateCtr @Var2Pharma @UBC

[Daugaard Laboratory @madsdaug1]

Getting close to launch now. Very exciting👍

[SnapCyte Solutions Inc. @snapcyte]

🔬 Discover SnapCyte: Your Cell Analytics Gateway! 🚀
✨ Upgrade your microscope with SnapCyte™ App. 📱💡
🔎 Snap, check, and know cell confluency in seconds using AI. 📸💪
Join SnapCyte today! ✨🌍
#biotech #AI #lifescience #biology #CellAnalytics #Breakthrough

[Daugaard Laboratory @madsdaug1]

Such an honour to be part of this phenomenal research environment. Happy anniversary VCHRI👍🥳

[VCH Research Institute @VCHResearch]

#VCHRI20Years – @VanProstateCtr investigator Dr. Mads Daugaard is up next with a presentation commemorating 10 years of research innovation & commercialization.

[SnapCyte Solutions Inc. @snapcyte]

Read more about our #jobopening 👇

[SnapCyte Solutions Inc. @snapcyte]

We are thrilled and can’t wait to meet you at the 2023 Investor Showcase 🚀
#UBCEnterpreneurship #vancouver

[Vancouver Prostate Centre @VanProstateCtr]

Our spinoff company, SnapCyte has two exciting job opportunities: Marketing Coordinator (https://t.co/ssTwc2deaT) and Lab Assistant (https://t.co/GFk8T4lKQb). If interested please click the links!

[Daugaard Laboratory @madsdaug1]

Great opportunity!

[SnapCyte Solutions Inc. @snapcyte]

📣We are #hiring! Read more about the #jobopportunity:

[SnapCyte Solutions Inc. @snapcyte]

Are you getting different cell confluence data than other lab members? With the SnapCyte™ app you get unbiased data in minutes, using your phone and lab microscope. Sign up to be a Beta Tester and first to try it below 👇
#AI #lifescience #biology

https://t.co/Lsj7gz3T3i

[Daugaard Laboratory @madsdaug1]

Have a sneak-peek at our novel bi-functional PARP and HDAC inhibitor that combines two different therapeutic modalities into one single molecule. PoC in Ewing sarcoma. #CancerResearch #PARPi #EwingSarcoma #StBaldricks #VanProstateCtr #VCHResearch #UBC https://t.co/24AlstnOSo

[VCH Research Institute @VCHResearch]

A study led by @VanProstateCtr researchers @nader_alnakouzi & @madsdaug1 has uncovered a vital clue behind the recurrence of prostate cancer following anti-androgen hormone therapy: https://t.co/kAPmXWYx1p

[Daugaard Laboratory @madsdaug1]

Congrats to my PhD student Zakir Tahiry and the other recipients of the 2022 PCFBC grant. Zakir is characterizing the prostate cancer glycocalyx in search for new targeting opportunities.

[Prostate Cancer Foundation Canada @prostatecanada]

Thanks to your incredible support, and contributions big and small, we are proud to announce that we have been able to grant a total of $535,000 towards prostate cancer research projects in Canada this year. Learn more about each project at https://t.co/5lHmqrLa70

[Daugaard Laboratory @madsdaug1]

Glad to see SnapCyte in this great lineup!

[Innovation UBC @innovationubc]

Meet the 18 teams taking the stage at the 2022 Venture Showcase!

We are excited for you to meet the ventures solving problems across climate, human health and social impact with new and returning ventures joining us at Robson Square Nov 23!

https://t.co/YtQMIptxDN

#VS22

[SnapCyte Solutions Inc. @snapcyte]

Today we signed the agreement with a Canadian investor!
“This investment will allow SnapCyte Solutions Inc. to introduce the SnapCyte™ app on the global market and initiate development of new product lines”, says Dr. Mads Daugaard, CEO. Read more below👇
https://t.co/EFORyXR6Qg

[The Nobel Prize @NobelPrize]

BREAKING NEWS:
The 2022 #NobelPrize in Physiology or Medicine has been awarded to Svante Pääbo “for his discoveries concerning the genomes of extinct hominins and human evolution.”

[Daugaard Laboratory @madsdaug1]

If you are working in a cell biology laboratory, please sign up for beta testing at https://t.co/FDNeGF6Xne

[Science in Vancouver @ScienceVancity]

🤳 Introducing @SnapCyte: a new #AI-powered app used in the analysis of cancer cells and other diseases at a microscopic scale! 🔬

💬 “The app returns precision data results within five minutes,” says CEO Dr. Mads Daugaard (@madsdaug1).
https://t.co/fKBOlPJQSd

[VCH Research Institute @VCHResearch]

#NewsRelease – An AI-driven smartphone app developed by @VanProstateCtr researcher Dr. Mads Daugaard will make affordable cell analytics accessible to scientists around the world: https://t.co/YQ8G1X2PX6 @madsdaug1 @UBCmedicine @VCHhealthcare

[Vancouver Prostate Centre @VanProstateCtr]

An AI-driven smartphone app developed by @VanProstateCtr researcher Dr. Mads Daugaard will make affordable cell analytics accessible to scientists around the world: https://t.co/zmDiGc0k1v @madsdaug1

[Daugaard Laboratory @madsdaug1]

Happy to announce the launch of our new venture SnapCyte Solutions Inc. that develops smartphone apps for life science research.

[SnapCyte Solutions Inc. @snapcyte]

We are SnapCyte Solutions Inc. and we are here to democratize life science research!
We are excited to announce our incorporation and letting you know that we are in business.
#biotech #AI #lifescience #biology https://t.co/XopTiFmNUi

[Daugaard Laboratory @madsdaug1]

This is a fantastic meeting for students and trainees working in the cell death, inflammation and cancer fields

[Lynn Wong @Lynn_Wong_ca]

The 13th EWCD is ON! June 4-9th, 2023 in Fiuggi, Italy at the Ambasciatori Hotel. Keep an eye for updates at https://t.co/RYscjhOzh9